UTV | COLOMBO – US biotech firm Moderna says it will enter the final stage of human trials for its Covid-19 vaccine on 27 July.
The company aims to enroll 30,000 people in its clinical trial – with participants receiving either the vaccine or a placebo.
Information about the trial, which was posted on clinicaltrials.gov, indicated that the study will run until October 2022.
Moderna’s latest announcement comes after the New England Journal of Medicine published results from the first stage of the trial – which showed its first 45 participants all developed antibodies to the virus.
Moderna is one of a handful of companies that are now in a global race to develop a vaccine – including pharmaceutical giants like AstraZeneca and Pfizer.
It typically takes years to develop a vaccine.